Aurora Therapeutics

📍 Cambridge, United States👥 9 employees💰 Last funded 2025
Biotechnology Research🌐 auroratherapeutics.com
Website LinkedIn
Aurora Therapeutics is reinventing how personalized gene-editing medicines are developed and approved for patients with rare diseases. The company combines state-of-the-art CRISPR engineering with umbrella regulatory pathways and modular CMC frameworks that allow many mutation-specific therapies to move forward in parallel. Aurora’s approach addresses the fundamental economic and operational barriers that have historically prevented treatments for rare mutations, enabling CRISPR therapies to reach patients at population scale. For more information, visit http://auroratherapeutics.com.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Aurora Therapeutics?
Aurora Therapeutics has 1 investors on record on gritt.io.
When did Aurora Therapeutics last raise funding?
The most recent investment in Aurora Therapeutics recorded on gritt.io was in 2025.
What industry is Aurora Therapeutics in?
Aurora Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Aurora Therapeutics based?
Aurora Therapeutics is headquartered in Cambridge, United States.